ATLAS / Macro Radar / Reporting / CLYM

Climb Bio, Inc. (CLYM) reporting calendar

Climb Bio, Inc. files periodic reports with the SEC as CLYM on Nasdaq. Atlas tracks 20 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
20 Jul 2026 – 4 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
20

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open CLYM market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001193125-26-210357
10-K31 Dec 20255 Mar 202664 days0001193125-26-092546
10-Q30 Sep 20256 Nov 202537 days0001193125-25-268086
10-Q30 Jun 202512 Aug 202543 days0000950170-25-106916
10-Q31 Mar 202514 May 202544 days0000950170-25-070902
10-K31 Dec 202425 Mar 202584 days0000950170-25-044350
10-Q30 Sep 202412 Nov 202443 days0000950170-24-125294
10-Q30 Jun 202414 Aug 202445 days0000950170-24-096626
10-Q31 Mar 202415 May 202445 days0000950170-24-059995
10-K31 Dec 202328 Mar 202488 days0000950170-24-038023
10-Q30 Sep 202314 Nov 202345 days0000950170-23-063675
10-Q30 Jun 202310 Aug 202341 days0000950170-23-041303
10-Q31 Mar 202311 May 202341 days0000950170-23-021186
10-K31 Dec 20226 Mar 202365 days0000950170-23-006279
10-Q30 Sep 202214 Nov 202245 days0000950170-22-024611
10-Q30 Jun 202215 Aug 202246 days0000950170-22-017181
10-Q31 Mar 202216 May 202246 days0000950170-22-009931
10-K31 Dec 20217 Mar 202266 days0000950170-22-002998
10-Q30 Sep 20218 Nov 202139 days0000950170-21-003448
10-Q30 Jun 202113 Sep 202175 days0000950170-21-001783

Source: SEC EDGAR company submissions for CIK 0001768446. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.